JKE-1674 |
| Catalog No.GC47477 |
JKE-1674는 경구 활성 글루타티온 퍼옥시다제 4(GPX4) 억제제이자 GPX4 억제제 ML-210의 활성 대사 산물입니다. JKE-1674, 니트로이속사졸 고리가 α-니트로케톡심으로 대체된 ML-210의 유사체. JKE-1674는 니트릴 산화물 JKE-1777로 변환할 수 있습니다. JKE-1674는 ML-210과 동일한 방식으로 LOX-IMVI 세포를 죽이고 ferroptosis 억제제에 의해 완전히 구제됩니다.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 2421119-60-8
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
JKE-1674 is an inhibitor of glutathione peroxidase 4 (GPX4) and an active metabolite of the GPX4 inhibitor ML-210 .1 JKE-1674 reduces viability of LOX-IMVI cancer cells (EC50 = 0.03 µM) and in a panel of additional cancer cell lines, an effect that can be blocked by the ferroptosis inhibitor ferrostatin-1 .
1.Eaton, J.K., Furst, L., Ruberto, R.A., et al.Selective covalent targeting of GPX4 using masked nitrile-oxide electrophilesNat. Chem. Biol.16(5)497-506(2020)
Average Rating: 5 (Based on Reviews and 23 reference(s) in Google Scholar.)
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *